Stellantis introduced early Monday that it plans a second U.S. battery plant to assist help American EV manufacturing.
With a memorandum of understanding signed between Stellantis and Samsung SDI Monday, the businesses search to start out manufacturing on the facility in 2027 and “an initial annual production capacity of 34 gigawatt-hours.” But the situation stays undisclosed and “currently under review,” in keeping with a launch.
The second battery plant will fall beneath the identical StarPlus Energy three way partnership as its first U.S. facility at the moment being inbuilt Kokomo, Indiana and attributable to ramp up in early 2025.
Furthermore, Stellantis reported that the Indiana plant will goal for an annual manufacturing of 33 gigawatt-hours, up from 23 when the challenge was introduced.
STLA Large platform – Stellantis EVs
Stellantis’ different proposed battery plant, a three way partnership with LG Energy Solution, had been stalled till earlier this month over points by which “the Canadian government has not delivered on what was agreed to.”
As of July 5, the businesses reported the challenge was again on, with the plant attributable to begin manufacturing in 2024, ramping as much as an annual output of greater than 45 gigawatt-hours.
That 4.5-million-square-foot manufacturing unit was beforehand attributable to be accomplished by the tip of 2023. The web site may even be serving as a expertise heart for cell, module, and battery-pack improvement for EVs, hybrids, and plug-in hybrids, however the firm hasn’t but commented on how this delay would possibly have an effect on these plans.
Stellantis additionally hasn’t but offered an replace on whether or not this impacts the timeline for the launch of upcoming EVs, doubtlessly together with the Ram 1500 REV electrical truck, a Dodge electrical muscle automobile, and a Jeep Recon that might act as a totally electrical “brother” to the Wrangler.
Samsung SDI cells have precedent in Stellantis’ U.S. EV lineup. The authentic Fiat 500e that first arrived for restricted U.S. sale a decade in the past was outfitted with cells from that firm.